216 related articles for article (PubMed ID: 36869794)
1. Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial.
Wang AY; Lo WK; Cheung SC; Tang TK; Yau YY; Lang BH
Nephrol Dial Transplant; 2023 Jul; 38(8):1823-1835. PubMed ID: 36869794
[TBL] [Abstract][Full Text] [Related]
2. Impact of Parathyroidectomy Versus Oral Cinacalcet on Bone Mineral Density in Patients on Peritoneal Dialysis With Advanced Secondary Hyperparathyroidism: The PROCEED Pilot Randomized Trial.
Wang AY; Tang TK; Yau YY; Lo WK
Am J Kidney Dis; 2024 Apr; 83(4):456-466.e1. PubMed ID: 38040277
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of parathyroidectomy versus cinacalcet in the clinical management of secondary hyperparathyroidism.
Kim WW; Rhee Y; Kim BS; Kim K; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Endocr J; 2019 Oct; 66(10):881-889. PubMed ID: 31189770
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism.
Eddington H; Chinnadurai R; Alderson H; Ibrahim ST; Chrysochou C; Green D; Erekosima I; Hutchison A; Bubtana A; Hegarty J; Kalra PA
BMC Nephrol; 2021 Mar; 22(1):106. PubMed ID: 33757437
[TBL] [Abstract][Full Text] [Related]
6. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.
Parfrey PS; Chertow GM; Block GA; Correa-Rotter R; Drüeke TB; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC; Dehmel B; Trotman ML; Modafferi DM; Goodman WG
J Clin Endocrinol Metab; 2013 Dec; 98(12):4834-44. PubMed ID: 24108314
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of cinacalcet withdrawal in Australian dialysis patients.
Ruderman I; Holt SG; Kirkland GS; Maslen S; Hawley CM; Oliver V; Krishnasamy R; Gray NA; Talaulikar GS; Nelson CL; Rajaram Y; Gock H; Au E; Elder GJ; Mainra R; Toussaint ND
Intern Med J; 2019 Jan; 49(1):48-54. PubMed ID: 29992701
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.
Joy MS; Karagiannis PC; Peyerl FW
J Manag Care Pharm; 2007 Jun; 13(5):397-411. PubMed ID: 17605511
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Secondary Hyperparathyroidism and Posttransplant Tertiary Hyperparathyroidism.
Egan CE; Qazi M; Lee J; Lee-Saxton YJ; Greenberg JA; Beninato T; Zarnegar R; Fahey TJ; Finnerty BM
J Surg Res; 2023 Nov; 291():330-335. PubMed ID: 37506432
[TBL] [Abstract][Full Text] [Related]
10. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
Zitt E; Rix M; Ureña Torres P; Fouque D; Jacobson SH; Pétavy F; Dehmel B; Ryba M
Nephrol Dial Transplant; 2011 Jun; 26(6):1956-61. PubMed ID: 20947534
[TBL] [Abstract][Full Text] [Related]
12. Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis.
Chen L; Wang K; Yu S; Lai L; Zhang X; Yuan J; Duan W
Ren Fail; 2016 Aug; 38(7):1050-8. PubMed ID: 27198474
[TBL] [Abstract][Full Text] [Related]
13. Parathyroidectomy: still the best choice for the management of severe secondary hyperparathyroidism.
Ramos LGF; Cortes DDPVR; Reis LMD; Montenegro FLM; Arap SS; Brescia MDG; Custódio MR; Jorgetti V; Elias RM; Moysés RMA
J Bras Nefrol; 2024; 46(2):e20230024. PubMed ID: 38039492
[TBL] [Abstract][Full Text] [Related]
14. Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis.
Warady BA; Ng E; Bloss L; Mo M; Schaefer F; Bacchetta J
Pediatr Nephrol; 2020 Sep; 35(9):1679-1697. PubMed ID: 32367309
[TBL] [Abstract][Full Text] [Related]
15. [Kidney and bone update : the 5-year history and future of CKD-MBD. Parathyroidectomy for secondary hyperparathyroidism].
Tominaga Y
Clin Calcium; 2012 Jul; 22(7):1083-8. PubMed ID: 22750941
[TBL] [Abstract][Full Text] [Related]
16. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism.
Moldovan D; Racasan S; Kacso IM; Rusu C; Potra A; Bondor C; Patiu IM; Gherman-Căprioară M
Int Urol Nephrol; 2015 Nov; 47(11):1871-7. PubMed ID: 26377492
[TBL] [Abstract][Full Text] [Related]
17. Parathyroidectomy vs Cinacalcet Among Patients Undergoing Hemodialysis.
Komaba H; Hamano T; Fujii N; Moriwaki K; Wada A; Masakane I; Nitta K; Fukagawa M
J Clin Endocrinol Metab; 2022 Jun; 107(7):2016-2025. PubMed ID: 35277957
[TBL] [Abstract][Full Text] [Related]
18. Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.
Cozzolino M; Ketteler M; Martin KJ; Sharma A; Goldsmith D; Khan S
Nephrol Dial Transplant; 2014 Apr; 29(4):899-905. PubMed ID: 24500308
[TBL] [Abstract][Full Text] [Related]
19. Total parathyroidectomy with forearm auto-transplantation improves the quality of life and reduces the recurrence of secondary hyperparathyroidism in chronic kidney disease patients.
Li JG; Xiao ZS; Hu XJ; Li Y; Zhang X; Zhang SZ; Shan AQ
Medicine (Baltimore); 2017 Dec; 96(49):e9050. PubMed ID: 29245308
[TBL] [Abstract][Full Text] [Related]
20. Effect of cinacalcet treatment on vascular arterial stiffness among peritoneal dialysis patients with secondary hyperparathyroidism.
Chow KM; Szeto CC; Kwan BC; Cheng PM; Pang WF; Leung CB; Li PK
Nephrology (Carlton); 2014 Jun; 19(6):339-44. PubMed ID: 24589316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
